CClinicalTrials.gg
Not yet recruitingNCT07852429Updated Oct 1, 2026

A Pilot Study of a DBT-Informed Caregiver Risk Management Workshop

An interventional study of Workshop and consultation for caregivers of at risk youth in Caregivers, Suicide and Nonsuicidal Self Injury, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Health services research

Updated Oct 1, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
12 Years and older
Sex
All
01

Study summary

The goal of this pilot clinical trial is to explore the feasibility and acceptability of implementing an intervention for caregivers in our health care system. The intervention is intended to provide information and consultation to caregivers of youth ages 12-26 years old who are at risk of self-harm (i.e., suicidal behaviors and/or nonsuicidal self-injury). The intervention is based on principles of Dialectical Behavior Therapy, an evidence-based intervention for youth who engage in suicidal behaviors and nonsuicidal self-injury. Acceptability will be assessed through questionnaires and qualitative feedback. Feasibility will be assessed by tracking the amount of clinician resources needed and how long it takes to identify caregivers who want to participate. A group of caregivers who have lived experience of having a child at risk for self-harm will form an advisory board. The board will review the study methods and data; their advice will guide next steps.

02

Conditions studied

  • Caregivers
  • Suicide
  • Nonsuicidal Self Injury
  • Adolescent
  • Young Adult
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's planned enrollment of 60 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Caregiver Participants Inclusion Criteria:

  • caregiver whose has a child age 12-26yo who is screens positive for risk of self-harm or suicide by a UCSF provider
  • speaks English

Caregiver Participants Exclusion Criteria:

  • no access to Zoom

Youth Participants Inclusion Criteria:

  • child age 12-26 yo of a caregiver who consents to participate in study
  • For youth 12-17 yo, legal guardian must be one of the caregivers participating and they also consent for this youth to participate in the study
  • speaks English

Youth Participants Exclusion Criteria:

  • no access to Zoom
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Intervention

    Behavioral: Workshop and consultation for caregivers of at risk youth

Interventions

  • BehavioralWorkshop and consultation for caregivers of at risk youth

    The caregiver intervention is provided via telehealth and uses principles and information adapted from Dialectical Behavior Therapy for Adolescents (DBT; Miller, Rathus, Linehan, 2007). It consists of 4 session, 90 minutes each, over a 4-week period. The information and actives during these sessions are intended to: (1) provide education about suicidal and self-injurious thoughts \& behaviors and effective interventions, (2) support caregivers to implement safety measures at home, (3) increase caregiver coping skills, and (4) teach caregivers skills to support youth behavior change. Caregivers who attend the sessions are encouraged to get consultation with the same provider outside of the sessions. Weekly "office hours" are scheduled and they can also make an ad hoc appointment. The consultation will be provided for up to 6 months following the sessions. Consultation is meant to help caregivers apply the information they learn in the sessions to their particular family situation.

06

What researchers measure

Primary outcomes

  1. Caregiver participant attendance rate

    The number of workshop and consultation sessions that caregivers attend will be used as a measure of acceptability.

    Time frame: enrollment to 6 month follow-up

  2. Caregiver participant survey & interview completion rate

    The number of surveys and interviews that caregivers complete will be a primary measure of feasibility and acceptability of study methods.

    Time frame: enrollment to 6-month follow-up

  3. Youth participant survey & interview completion rate

    The number of surveys and interviews that youth participants complete will be a primary measure of feasibility and acceptability of study methods.

    Time frame: enrollment to 6-month follow-up

07

Study locations

1 site
  • University of California, San Francisco
    San Francisco, California 94107, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07852429
Lead sponsor
University of California, San Francisco
Responsible party
Sponsor
First posted
Oct 1, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Apr 28, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Oct 1, 2026

Study contacts

Sabrina Darrow, PhD
Contact
Sabrina.Darrow@ucsf.edu
(415) 476-3395
Sabrina Darrow, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion